Suraksha Diagnostic IPO details, GMP and key things

The Suraksha Diagnostic IPO is set to open for subscription on November 29, 2024, and will close on December 3, 2024. Investors who apply for this IPO can expect to receive updates about the allotment status on December 4, 2024.

The Suraksha Diagnostic IPO will be open for subscription from November 29, 2024, to December 3, 2024, as per the company’s offer document filed with SEBI. Investors can check the allotment status on December 4, 2024. Those allotted shares will have them credited to their demat accounts by December 5, 2024, and the shares will be listed on the NSE and BSE on December 6, 2024.

Established in 2005, Suraksha Diagnostic is a leading provider of integrated pathology, radiology, and medical consultation services, primarily in Eastern India, including states like West Bengal, Bihar, Assam, and Meghalaya. By June 30, 2024, the company offered over 2,300 tests across various specialties, including 788 routine pathology tests and 766 radiology tests like MRI and CT scans. In FY2024, Suraksha conducted nearly 5.98 million tests and served 1.14 million patients through both online and offline medical consultation services.

Suraksha operates on a hub-and-spoke model, where 13 central hub centers process samples collected from 11 medium centers, 23 small centers, 2 public-private partnership centers, and 166 sample collection points. Despite a competitive market with players like Dr. Lal Pathlabs, Metropolis Healthcare, and Thyrocare Technologies, Suraksha holds a 1.15%-1.30% market share in Eastern India as of FY2024.

Key things about Suraksha Diagnostic IPO :

Suraksha Diagnostic IPO: The Suraksha Diagnostic IPO will be open for subscription from November 29 to December 3, 2024.

Suraksha Diagnostic IPO price band: The price band for the Suraksha Diagnostic IPO is set between ₹420 and ₹441 per share.

Suraksha Diagnostic IPO lot size: The Suraksha Diagnostic IPO issue size is approximately ₹846.25 crore, with a minimum application of 34 shares per lot.

Suraksha Diagnostic IPO details: Suraksha Diagnostic, primarily operating in Eastern India, offers over 2,300 diagnostic tests across various specialties, including pathology and radiology, with services like MRI and CT scans. The company operates through a hub-and-spoke model, where 13 hub centers handle sample processing and 166 sample collection points facilitate testing. In FY24, Suraksha conducted 5.98 million tests and served 1.14 million patients, generating over 95% of its revenue from Kolkata and West Bengal. Despite facing strong competition from industry leaders like Dr. Lal Pathlabs and Metropolis Healthcare, the company stands to benefit from the projected growth of the Indian diagnostics market, which is expected to expand from ₹860-870 billion in FY2024 to ₹1,357 billion by FY2028.

Suraksha Diagnostic IPO objective: The proceeds from the IPO will go to the selling shareholders, and the company will not receive any funds from this issue. The company aims to list its shares on the stock exchanges to increase its visibility and improve its brand image.

Suraksha Diagnostic IPO Listing date: The listing date for the Suraksha Diagnostic IPO is December 6, 2024.

Suraksha Diagnostic IPO GMP: The Grey Market Premium (GMP) for the Suraksha Diagnostic IPO is currently 0.

Disclaimer: We do not recommend applying for this IPO. We provide only the IPO details for informational purposes. If you are interested in investing in this IPO, please consult with your financial advisor before making any decisions.